164 related articles for article (PubMed ID: 1839760)
1. Treatment of encrusted cystitis caused by Corynebacterium group D2 with norfloxacin, ciprofloxacin, and teicoplanin in an experimental model in rats.
Soriano F; Rodriguez-Tudela JL; Castilla C; Avilés P
Antimicrob Agents Chemother; 1991 Dec; 35(12):2587-90. PubMed ID: 1839760
[TBL] [Abstract][Full Text] [Related]
2. Teicoplanin treatment of alkaline encrusted cystitis due to Corynebacterium group D2.
Estorc JJ; de La Coussaye JE; Viel EJ; Bouziges N; Ramuz M; Eledjam JJ
Eur J Med; 1992 Jun; 1(3):183-4. PubMed ID: 1341439
[TBL] [Abstract][Full Text] [Related]
3. [Incrusted cystitis with isolation of Corynebacterium group D2].
Fernández Natal MI; García Díez F; Salas Valién JS; Cachón García F; Soriano García F
Med Clin (Barc); 1992 Mar; 98(11):419-22. PubMed ID: 1533260
[TBL] [Abstract][Full Text] [Related]
4. [Corynebacterium D2-induced encrusted cystitis].
Molina M; Ortega G; Ruiz J; Pérez García A; Saez JA; Serrano J
An Med Interna; 1989 Dec; 6(12):641-2. PubMed ID: 2491476
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of Corynebacterium urealyticum encrusted cystitis: a case report and literature review.
Pierciaccante A; Pompeo ME; Fabi F; Venditti M
Infez Med; 2007 Mar; 15(1):56-8. PubMed ID: 17515676
[TBL] [Abstract][Full Text] [Related]
6. An encrusted cystitis caused by Corynebacterium urealyticum in a dog.
Gomez A; Nombela C; Zapardiel J; Soriano F
Aust Vet J; 1995 Feb; 72(2):72-3. PubMed ID: 7779042
[No Abstract] [Full Text] [Related]
7. Increasing incidence of Corynebacterium group D2 strains resistant to norfloxacin and ciprofloxacin.
Soriano F; Fernández-Roblas R; Zapardiel J; Rodríguez-Tudela JL; Avilés P; Romero M
Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1117-8. PubMed ID: 2620675
[No Abstract] [Full Text] [Related]
8. [Corynebacterium urealyticum in renal trasplantation. CT and sonography imaging characteristics of encrusted cistitis and pielitis].
Vázquez V; Morales MD; Serrano C; Reus M; Llorente S; García J
Nefrologia; 2004; 24(3):288-93. PubMed ID: 15283321
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo study of stone formation by Corynebacterium group D2 (Corynebacterium urealyticum).
Soriano F; Ponte C; Santamaría M; Castilla C; Fernández Roblas R
J Clin Microbiol; 1986 Apr; 23(4):691-4. PubMed ID: 3517059
[TBL] [Abstract][Full Text] [Related]
10. Corynebacterium group D2 as a cause of alkaline-encrusted cystitis: report of four cases and characterization of the organisms.
Soriano F; Ponte C; Santamaria M; Aguado JM; Wilhelmi I; Vela R; Delatte LC
J Clin Microbiol; 1985 May; 21(5):788-92. PubMed ID: 3998111
[TBL] [Abstract][Full Text] [Related]
11. [Norfloxacine efficacy in acute cystitis in the region with 10% resistance of E. coli to fluoroquinolones: a comparative randomized study].
Rafal'skiĭ VV; Malev IV; Derevitskiĭ AV; Kozlov SN; Galkin VV
Urologiia; 2009; (3):18-21. PubMed ID: 19670810
[TBL] [Abstract][Full Text] [Related]
12. Encrusted cystitis and pyelitis in children: an unusual condition with potentially severe consequences.
Meria P; Margaryan M; Haddad E; Dore B; Lottmann HB
Urology; 2004 Sep; 64(3):569-73. PubMed ID: 15351595
[TBL] [Abstract][Full Text] [Related]
13. [Conservative management of Corynebacterium urealyticum encrusted cystitis].
Khallouk A; Wallerand H; Kleinclauss F; Bittard H; Bernardini S
Prog Urol; 2006 Sep; 16(4):496-8. PubMed ID: 17069049
[TBL] [Abstract][Full Text] [Related]
14. [Corynebacterium group D2. Clinical study, biochemical identification and antibiotic sensitivity].
Marty N; Clave D; Cancet B; Henry-Ferry S; Didier J
Pathol Biol (Paris); 1988 May; 36(5):460-4. PubMed ID: 3136426
[TBL] [Abstract][Full Text] [Related]
15. Encrusted cystitis caused by corynebacterium urealyticum: a case report with novel treatment strategy of intravesical dimethyl sulfoxide.
Ozkan TA; Yalcin MS; Dillioglugil O; Cevik I
Int Braz J Urol; 2018; 44(6):1252-1255. PubMed ID: 29697935
[TBL] [Abstract][Full Text] [Related]
16. Corynebacterium group D2 urinary tract infection.
Stewart RG; Nowbath V; Carmichael M; Klugman KP
S Afr Med J; 1993 Feb; 83(2):95-6. PubMed ID: 8451711
[TBL] [Abstract][Full Text] [Related]
17. Activity of E-3846, a new fluoroquinolone, in vitro and in experimental cystitis and pyelonephritis in rats.
Gargallo D; Moros M; Coll R; Esteve M; Parés J; Xicota MA; Guinea J
Antimicrob Agents Chemother; 1988 May; 32(5):636-41. PubMed ID: 3134844
[TBL] [Abstract][Full Text] [Related]
18. [Two cases of encrusted cystitis].
Ohara H; Yoshimura K; Terada N; Ichioka K; Matsui Y; Terai A; Arai Y
Hinyokika Kiyo; 2004 Jan; 50(1):33-5. PubMed ID: 15032013
[TBL] [Abstract][Full Text] [Related]
19. Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study.
Arredondo-García JL; Figueroa-Damián R; Rosas A; Jáuregui A; Corral M; Costa A; Merlos RM; Ríos-Fabra A; Amábile-Cuevas CF; Hernández-Oliva GM; Olguín J; Cardeñosa-Guerra O;
J Antimicrob Chemother; 2004 Oct; 54(4):840-3. PubMed ID: 15347634
[TBL] [Abstract][Full Text] [Related]
20. Encrusted cystitis causing postrenal failure.
Tanaka T; Yamashita S; Mitsuzuka K; Yamada S; Kaiho Y; Nakagawa H; Arai Y
J Infect Chemother; 2013 Dec; 19(6):1193-5. PubMed ID: 23605319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
